Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions

Paul S Teirstein, Ian T Meredith, Robert L Feldman, Charles A Rabinowitz, Louis A Cannon, Tommy C Lee, Joseph Dens, Christophe L Dubois, Michael R Mooney, Vincent J Pompili, Shigeru Saito, Dominic J Allocco, Keith D Dawkins, Gregg W Stone

Research output: Contribution to journalArticleResearchpeer-review

19 Citations (Scopus)

Abstract

OBJECTIVES: To report 1- and 2-year clinical outcomes of patients receiving platinum chromium everolimus-eluting stents (PtCr-EES) in the prospective, single-arm PLATINUM small vessel (SV) and long lesion (LL) studies. BACKGROUND: Small vessel diameter and long lesion length are independently associated with increased risk of adverse cardiac events after drug-eluting stent implantation. METHODS: The PLATINUM SV study enrolled 94 patients with coronary artery lesions in vessels >/=2.25 mm to 24 to /=2.50 to
Original languageEnglish
Pages (from-to)207 - 215
Number of pages9
JournalCatheterization and Cardiovascular Interventions
Volume85
Issue number2
DOIs
Publication statusPublished - 2015

Cite this

Teirstein, P. S., Meredith, I. T., Feldman, R. L., Rabinowitz, C. A., Cannon, L. A., Lee, T. C., Dens, J., Dubois, C. L., Mooney, M. R., Pompili, V. J., Saito, S., Allocco, D. J., Dawkins, K. D., & Stone, G. W. (2015). Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions. Catheterization and Cardiovascular Interventions, 85(2), 207 - 215. https://doi.org/10.1002/ccd.25565